|
|
Gene Symbol |
REN |
|
Aliases |
HNFJ2 |
|
Entrez Gene ID |
|
|
Gene Name |
Renin |
|
Chromosomal Location |
1q32.1 |
|
HGNC ID |
|
|
Summary |
Renin catalyzes the first step in the activation pathway of angiotensinogen--a cascade that can result in aldosterone release,vasoconstriction, and increase in blood pressure. Renin, an aspartyl protease, cleaves angiotensinogen to form angiotensin I, which is converted to angiotensin II by angiotensin I converting enzyme, an important regulator of blood pressure and electrolyte balance. Transcript variants that encode different protein isoforms and that arise from alternative splicing and the use of alternative promoters have been described, but their full-length nature has not been determined. Mutations in this gene have been shown to cause familial hyperproreninemia. [provided by RefSeq, Jul 2008]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Renin, angiotensin-forming enzyme, angiotensinogenase, renin precursor, renal |
|
Function |
Renin is a highly specific endopeptidase, whose only known function is to generate angiotensin I from angiotensinogen in the plasma, initiating a cascade of reactions that produce an elevation of blood pressure and increased sodium retention by the kidney |
|
|
|
|
|
UniProt |
|
|
PDB |
2X0B, 6I3F, 1BBS, 1BIL, 1BIM, 1HRN, 1RNE, 2BKS, 2BKT, 2FS4, 2G1N, 2G1O, 2G1R, 2G1S, 2G1Y, 2G20, 2G21, 2G22, 2G24, 2G26, 2G27, 2I4Q, 2IKO, 2IKU, 2IL2, 2REN, 2V0Z, 2V10, 2V11, 2V12, 2V13, 2V16, 3D91, 3G6Z, 3G70, 3G72, 3GW5, 3K1W, 3KM4, 3O9L, 3OAD, 3OAG, 3OOT, 3OQF, 3OQK, 3OWN, 3Q3T, 3Q4B, 3Q5H, 3SFC, 3VCM, |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000215832 |
P28482 |
P28482 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Blood Disorders |
Anemia |
|
Cardiovascular Diseases |
Heart Failure |
|
Hypertensive disease |
12600921, 7721401, 19770776, 18679781, 1149188, 18847324, 62162, 998518, 6381767, 17537837, 21393355, 12414515, 20429690, 1071603, 45830, 20811386, 11501062 |
Left Ventricular Hypertrophy |
|
Malignant Hypertension |
|
Myocardial Failure |
|
Myocardial Infarction |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Renal Tubular Dysgenesis With Choanal Atresia And Athelia |
|
Digestive System Diseases |
Liver Fibrosis |
|
Liver Cirrhosis |
|
Endocrine System Diseases |
Bartter Disease |
|
PCOS |
|
Musculoskeletal Diseases |
Osteoporosis |
|
Nutritional and Metabolic Diseases |
Liddle Syndrome |
|
Psychiatric/Brain disorders |
Mental Depression |
|
Bipolar Disorder |
|
Obstructive Sleep Apnea |
|
Renal Disorder |
Allanson Pantzar McLeod syndrome |
|
Hyperuricemic Nephropathy |
|
Nephrosis |
|
Azotemia |
|
Reproductive disorders |
Preeclampsia |
|
Skin and Connective Tissue Diseases |
Pustulosis |
|
Psoriasis |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
|
PCOS, insulin resistance |
|
Polycystic ovary syndrome was defined as the presence of bilateral polycystic ovaries on ultrasound examination, oligomenorrhea or amenorrhea and/or chronic anovulation, and hyperandrogenemia (high serum T and/or free T and/or 17-OHP). |
Related
|
25 normotensive women with PCOS, 11 normotensive control women |
The plasma totalreninlevel is higher in normotensive women withPCOSthan in healthy women independent of insulin resistance |
|
PANG II |
PCOS |
|
|
Related
|
30 PCOS and 30 Control |
PRA and PANG II suggest an enhanced functional activity of ovarian renin angiotensin system in PCOS |
|
|
PCOS |
|
Adamset al., 1985 |
Related
|
40 PCOS, 30 non-PCOS oligomenorrheic and 30 Control |
Plasma renin activity can be used together with other variables to diagnose women withPCOSand to distinguish non-PCOS oligomenorrheic women from those withPCOS |
|
Aldosterone levels |
|
|
|
Related
|
34 Obese PCOS and 13 Non obesePCOS |
differences exist in plasma renin and aldosterone levels between obese and non-obese women as compared with PCOS and normal controls |
|
VEGF |
|
|
|
Related
|
20 PCOS |
Follicular maturation and oocyte quality are related to the intrafollicular influences of active renin and VEGF |
|
|
Infertility |
|
Polycystic ovary syndrome was defined as the presence of bilateral polycystic ovaries on ultrasound examination (10), oligomenorrhea or amenorrhea and/or chronic anovulation (11), and hyperandrogenemia (high serum T and/or free T and/or 17-OHP) |
Related
|
11 PCOS |
Against our basic hypothesis the serum total renin levels remained unaltered after ovarian electrocautery, while the serum levels of luteinizing hormone, testosterone and androstenedione declined. The mechanism that induces ovulation without altering total renin levels in serum remains to be resolved. |
|
FF |
|
|
|
Related
|
|
Concentrations of total renin in plasma markedly after gonadotropin stimulation with PCOD compared with women having tubal infertility |
|
ACE |
PCOS |
|
Rotterdam criteria |
Related
|
41 PCOS and 29 Control |
Obese PCOS women had higher total renin levels but not ACE activity and aldosterone levels as compare with control |
|
|
PCOS |
|
|
Direct
|
44 oligomenorrheic women with PCOS, 25 control women |
The elevated concentration of serum totalreninsuggests an enhanced activity of ovarianrenin-angiotensin system inPCOS. |
|
|
PCOS |
|
|
Related
|
7 PCOD ovaries |
This study highlights the link between the ovarianrenin-angiotensin system and those ovarian compartments known to be actively engaged in androgen secretion and/or luteinization and suggests that there may be an association between the ovarianrenin-angiotensin system and PCOD. |
|
|
PCOS |
|
|
Direct
|
47 women undergoing (IVF) were enrolled: 20 women with PCO, 27 controls |
Lower follicular fluid prorenin concentrations in women with PCO show that the synthesis of prorenin in theca cells starts later after HCG administration than in normally cycling women |
|
|
PCOS |
|
|
Related
|
30 PCOS women (15 women with LH/FSH > or = 3, 15 women with LH/FSH < 3), 20 controls |
There is enhanced RAS function inPCOSespecially in PCOS women with LH/FSH > or = 3 |
|
|
PCOS |
|
|
Direct
|
28 infertile women (13 PCOS, 15 controls) |
Infertile women withPCOShave higher baseline prorenin levels when compared with age- and weight-matched ovulatory controls. |
|
|
|
|